Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_4
6
75%
Ph phase_2
2
25%

Phase Distribution

0

Early Stage

2

Mid Stage

6

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
2(25.0%)
Phase 4Post-market surveillance
6(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(4)
Terminated(1)
Other(3)

Detailed Status

Completed4
unknown3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
80.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (25.0%)
Phase 46 (75.0%)

Trials by Status

completed450%
terminated113%
unknown338%

Recent Activity

0 active trials
Showing 5 of 8
unknownphase_4

FSH Followed by HMG vs FSH Plus HMG in IVF

NCT04385342
unknownphase_4

Androgenic Profile Following Controlled Ovarian Stimulation

NCT02992808
unknownphase_4

Use of Corifolitropin Alfa in Oocyte Donors

NCT02213627
completedphase_4

Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist

NCT01888744
completedphase_2

Corifollitropin Alfa Followed by hpHMG in a Long GnRH Agonist Protocol for the Treatment of Poor Ovarian Responders

NCT01732094
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT04385342Phase 4

FSH Followed by HMG vs FSH Plus HMG in IVF

Unknown
NCT02992808Phase 4

Androgenic Profile Following Controlled Ovarian Stimulation

Unknown
NCT02213627Phase 4

Use of Corifolitropin Alfa in Oocyte Donors

Unknown
NCT01888744Phase 4

Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist

Completed
NCT01732094Phase 2

Corifollitropin Alfa Followed by hpHMG in a Long GnRH Agonist Protocol for the Treatment of Poor Ovarian Responders

Completed
NCT01732068Phase 2

Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol

Completed
NCT01345812Phase 4

Time-lapse Evaluation of Embryo Development After Stimulation With One of Two Different Gonadotrophins.

Terminated
NCT00829075Phase 4

Impact of Three Different Gonadotrophin Regimes on Egg Donation Program

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8